ANDA 76502, held by Dr. Reddy's Laboratories. Fexofenadine Hydrochloride.
As of Nov 21, 2026, ANDA 76502 (Fexofenadine Hydrochloride, Children's Fexofenadine Hydrochloride Allergy, Children's Fexofenadine Hydrochloride Hives), held by Dr. Reddy's Laboratories, was first approved by FDA on Apr 11, 2006, with 4 approved supplements and 0 published complete response letters.
Use(s) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 11, 2006 | Original application | Approved | None posted |
| Fexofenadine Hydrochloride30MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride60MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride180MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Children's Fexofenadine Hydrochloride Allergy30MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Children's Fexofenadine Hydrochloride Hives30MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Fexofenadine Hydrochloride Allergy60MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Fexofenadine Hydrochloride Hives60MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Fexofenadine Hydrochloride Allergy180MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Fexofenadine Hydrochloride Hives180MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Jan 2, 2013 | Supplement 9Manufacturing | Approved | None posted |
| Sep 23, 2011 | Supplement 8Manufacturing | Approved | None posted |
| Apr 12, 2011 | Supplement 7Manufacturing | Approved | None posted |
| Jan 14, 2009 | Supplement 2Labeling | Approved | None posted |
| Apr 11, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters